Seong-Chul Kim
Direktor/Vorstandsmitglied bei KPS CORPORATION
Vermögen: 3 Mio $ am 30.04.2024
Profil
Seong-Chul Kim is the founder of Elevar Therapeutics, Inc. which was founded in 2005.
He held the titles of President, Chief Executive Officer & Director.
Currently, he is a Director at KPS Corp.
(South Korea) where he still holds a job.
In the past, he worked as Co-Chief Executive Officer at LSK Investment Co. Ltd.
from 2016 to 2018 and as Director & Head-Bio at HLB Co., Ltd.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
KPS CORP
2,94% | 03.04.2024 | 550 458 ( 2,94% ) | 3 Mio $ | 30.04.2024 |
Aktive Positionen von Seong-Chul Kim
Unternehmen | Position | Beginn |
---|---|---|
KPS CORPORATION | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Seong-Chul Kim
Unternehmen | Position | Ende |
---|---|---|
LSK Investment Co. Ltd.
LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Vorstandsvorsitzender | 31.12.2018 |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Gründer | - |
HLB CO., LTD. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HLB CO., LTD. | Health Technology |
Private Unternehmen | 3 |
---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
LSK Investment Co. Ltd.
LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Finance |
KPS Corp. (South Korea) |